• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Role of nutritional status and nutritional support in outcome of hepatitis B virus-associated acute-onchronic liver failure

    2020-11-30 06:58:14YueChangQinYuLiuQingZhangYaMeiRongChengZhenLuHaiLi
    World Journal of Gastroenterology 2020年29期

    Yue Chang, Qin-Yu Liu, Qing Zhang, Ya-Mei Rong, Cheng-Zhen Lu, Hai Li

    Abstract

    Key words: Liver failure; Hepatitis B; Nutrition therapy; Intestinal host defense; Cytokine; Prognosis

    INTRODUCTION

    Liver failure, in which liver cell function cannot meet the physiological needs of the human body, is a clinically common serious liver disease[1]. Globally, hepatitis B virus (HBV)-related liver failure is an important issue. Due to the high level of HBV infection in China, HBV-associated acute-on-chronic liver failure (HBV-ACLF) is a major burden as well[2]. The condition of patients with HBV-ACLF results in impaired nutrient synthesis and absorption, due to inadequate nutritional intake, abnormal liver structure, and functional failure[3]. At the same time, malnutrition will further aggravate the liver injury, affecting the quality of life and survival time[4].At present, malnutrition in most patients with liver disease progresses slowly, so it is particularly important to screen for nutritional risk in the early stage of the disease[5,6]. Therefore, more attention should be paid to nutritional risk screening and corresponding nutritional support[7]. However, in the past, the treatment of acute-onchronic liver failure relied too much on drugs and artificial liver support[8], ignoring basic nutritional support. In addition, the data on nutritional risk screening and nutritional status assessment in patients with liver failure is still insufficient.

    The gastrointestinal tract is not only involved in digestion and absorption but also has an important barrier function[9]. In the gastrointestinal tract, there is the largest pool of bacteria in the human body. Intestinal flora plays an important role in immunity and biological antagonism to the host[10]. The gastrointestinal tract is the central organ of the body to produce a stress response, and for the liver, it is the first organ to be impacted after the intestinal barrier is damaged[11]. The destruction of the intestinal barrier can be seen in the animal model of liver failure, indicating that liver injury will further aggravate the damage to the intestinal function[12]. In addition, intestinal endotoxin and cytokines are important causes of liver failure, that is, these findings indirectly proved that the damage of the intestinal barrier has a serious effect on the liver[13,14]. Thus far, the effect of improving nutritional status on gastrointestinal barrier function in patients with acute-on-chronic liver failure has not been determined.

    As the nutritional status of HBV-ACLF patients has been poorly studied, we investigated the nutritional risk and nutritional status of HBV-ACLF patients and evaluated the impact of nutritional support on the gastrointestinal barrier and 28-d mortality in patients with HBV-ACLF.

    MATERIALS AND METHODS

    Patients

    This study consisted of two parts. For Study 1, the changes in serum markers and cytokines related to nutritional risk, nutritional status, and intestinal barrier function were compared between HBV-ACLF patients and patients with compensated cirrhosis (control group). A total of 234 HBV-ACLF patients were recruited and admitted to Characteristic Medical Center of People's Armed Police Force, Tianjin Xiqing Hospital, and Tianjin Second People's Hospital from January 2016 to December 2018. All participants provided written informed consent in line with the Declaration of Helsinki. This study was registered with ClinicalTrials.gov (NCT03108794 and NCT01938820).

    The inclusion criteria were: (1) HBV-ACLF diagnosis and staging according to the consensus recommendations of the Asian-Pacific Association for the Study of the Liver (APASL): Jaundice (serum bilirubin ≥ 5 mg/dL) and coagulopathy [international normalized ratio (INR) ≥ 1.5 or prothrombin activity (PTA) < 40%] complicated within four week by ascites and/or encephalopathy[15]; and (2) Hospitalization for more than 48 h. Patients with hepatocellular carcinoma or other tumors; who had undergone hepatectomy; combined with other liver diseases and unconscious; and who could not cooperate with the investigation were excluded from this study.

    Propensity score matching was used to screen patients with HBV-related compensated liver cirrhosis at a ratio of 1:1. The matched patients had the same sex and age as the HBV-ACLF group. None of them were complicated with other hepatitis virus infections.

    For Study 2, HBV-ACLF patients treated in the same hospital from January 2014 to December 2016 were collected retrospectively as a control group. None of these patients had undergone nutritional risk screening or nutritional status assessment. The 28-d survival of the control group was compared with HBV-ACLF patients in Study 1. The flowchart of this study is shown in Figure 1.

    Demographic and clinical characteristics

    The venous blood of the subjects included in Study 1 was collected at admission for laboratory tests. Platelet (PLT) was tested using an automatic blood analyzer (Mindray BC-6800, China). The biochemical indexes alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), Total bilirubin level (TBIL), gamma-glutamyl transferase, and creatinine (Cr) were detected by biochemical analysis (Mindray BS-200, China). The coagulation function indicators prothrombin time (PT), INR, and PTA were detected with an automatic coagulation analyzer (SysmexCS5100, Japan). HBVDNA was detected by fluorescence quantitative polymerase chain reaction (ABI 7500FAST, Life Technologies, United states). The model for end-stage liver disease (MELD) score was calculated as follows:R= 9.6 ×loge (Cr, mg/dL)+ 3.8 ×loge (TBIL, mg/dL)+ 11.2 ×loge (INR)+6.4[16]. All these data were also collected or calculated for the non-nutritional support group in Study 2.

    Nutritional risk screening and nutritional status assessment

    All nutritional evaluation and marker tests were performed at the time of diagnosis and 2 wk and 4 wk after treatment.

    Nutritional risk screening (NRS) 2002 was used to assess the nutritional status, severity, and age of the patients. If the three scores added up to more than or equal to 3 points, the patient was considered to have a nutritional risk[17].

    Figure 1 Overview of this study. HBV-ACLF: Hepatitis B virus-associated acute-on-chronic liver failure; HCV: Hepatitis C virus infection; HCC: Hepatocellular carcinoma.

    According to the improved subjective global assessment (SGA) score sheet, the nutritional status of the patients was evaluated by specialized medical personnel. Muscle consumption was defined when fatigue, muscle soreness, and elevated blood creatine kinase were present, and the thickness of the triceps skinfold (TSF) was evaluated. Each indicator consisted of A, B, and C corresponding to 1, 2, and 3 points, respectively. Finally, the patient's total SGA score was calculated, which consisted of 7 to 21 points. TSF was measured by two professional trainers using a fixed soft ruler and fold meter. The right hand was measured with a sebum thickness meter three times.

    Human body composition was observed in the HBV-ACLF patients and the control group. According to the instructions, the body composition analyzer (Inbody 3.0, BiospaceCo., Ltd., South Korea) was used to determine the protein, fat, and skeletal muscle contents using the multifrequency bioelectrical impedance method.

    Biomarkers of the gastrointestinal barrier

    Enzyme linked immunosorbent assay (ELISA) was used to detect secretory immunoglobulin A (sIgA) in feces (Abcam, Cambridge, UK). The coccus-bacillus ratio was measured by direct smear in the laboratory department.

    Biomarkers of inflammation

    ELISA was used to detect D-lactate (Becton, Dickinson and Company, United states) and endotoxin (Abcam, Cambridge, UK) in serum at the time of diagnosis and 2 wk and 4 wk after treatment.

    Centralized testing for cytokines was performed by Jingmei Beijing Central Laboratory. Serum interleukin-1 (IL-1), interleukin-10 (IL-10), and tumor necrosis factor alpha (TNF-α) were detected with a Luminex-100 flow fluorescence microsphere detector (Luminex, Austin, TX, United states) according to the detection procedure. The levels of IL-1, IL-10, and TNF-α were detected using a human cytokine commercial kit (Becton, Dickinson and Company, United states).

    Nutritional intervention

    All HBV-ACLF patients had a light diet, licorice preparation, glutathione, albumin, fresh plasma, and other drugs to protect liver cells. Artificial extracorporeal liver support was considered in critical patients[15].

    In Study 1, HBV-ACLF patients were given individualized nutritional support by the nutrition support team. Nutritional support was initiated promptly for malnourished HBV-ACLF patients. Patients without malnutrition were provided with enteral nutrition (preferentially) and/or parenteral nutrition if they were viewed as unlikely to resume normal nutrition within the next 5-7 d. The nutritional composition and calories in the intestine of the patients were calculated by using the principle of small multi-meals and referring to the nutritional composition table. HBV-ACLF patients were encouraged to receive late evening oral nutritional supplementation in dietary habit. During hospitalization, total energy intake for HBV-ACLF patients was not lower than 35 kcal/(kg·d), while protein intake was not lower than 1.2-1.5 g/(kg·d)[18]. Total nutrition, carbohydrate, protein, and lipid were collected and calculated daily by 24-h dietary recalls[19]. Nutrition was supplemented by fresh plasma, albumin, glucose, and medium/long-chain fat emulsion on the second day of deficiency, while water-soluble and fat-soluble vitamins were supplemented to maintain the water-electrolyte balance. Branched-chain amino acids were supplied when adequate nitrogen intake was not achieved. If necessary, parenteral nutrition and calories were combined. The nutritional intake was re-assessed every day. According to the EASL guidelines, sodium intake was restricted to 80 mmol·d in patients with ascites[7]. Vitamin D was supplemented in patients with a vitamin D level < 20 ng/mL until serum 25 (OH) D > 30 ng/mL[18].

    In Study 2, the HBV-ACLF non-nutritional support group was also treated with licorice preparation, glutathione, albumin, and fresh plasma to protect liver cells, but no individualized total intake calculation and nutritional support were performed. Only albumin and fresh plasma were given intermittently, and no long-chain fat emulsion was used.

    Statistical analysis

    Statistical analyses were performed using Student’st-test, Welch’st-test, Mann-Whitney U test, chi-square test, or ANOVA, as appropriate. A receiver operating characteristic (ROC) curve was constructed using different markers to predict death in patients with HBV-ACLF. Youden’s index was used to determine the best cut-off value. The prognosis of patients with HBV-ACLF in the nutritional support group and the non-nutritional support group was analyzed using the Kaplan-Meier method. All statistical analyses were performed using Statistical Product and Service Solutions version 22.0 (IBM Corp., New York State, United states) and GraphPad Prism 7 (GraphPad Software Inc., San Diego, CA, United states).P< 0.05 was accepted as statistically significant.

    RESULTS

    Nutritional status of the two groups

    According to the NRS 2002 assessment, the nutritional risk of the HBV-ACLF group at admission was significantly higher than that of the control group (214/234vs158/234,P< 0.001) (Figure 2A). The average energy intake [18.1 ± 5.0 kcal / (kg·d)] was significantly lower in the HBV-ACLF group than in the control group [36.6 ± 4.8 kcal/(kg·d)] (P< 0.001; Figure 2B). According to the results of the body composition analysis, the skeletal muscle (25.3 ± 2.4 kgvs26.8 ± 2.6 kg), protein (5.9 ± 0.9 kgvs7.8 ± 1.12 kg), and body fat (16.1 ± 1.3 kgvs21.4 ± 3.1 kg) levels in the HBV-ACLF group were significantly lower than those of the control group, while the decrease in skeletal muscle and fat content was more pronounced (Figure 2C). At hospital admission, the intake of calories in patients with HBV-ACLF (13.9 ± 1.5 kgvs26.7 ± 3.2 kg), protein (1.7 ± 0.3 kgvs3.0 ± 0.3 kg), and fat (2.8 ± 0.5 kgvs7.4 ± 1.2 kg) were lower than those of the control group, and the deficiency of fat intake was more obvious (Figure 2D). The baseline characteristics of the HBV-ACLF group and the control group are shown in Table 1.

    The SGA scores in the HBV-ACLF group were significantly higher than those in the control group (P< 0.001), while the TSF in the HBV-ACLF group was lower (P< 0.001), indicating that there was excessive fat consumption in patients with HBVACLF (Figure 3).

    Table 1 Baseline characteristics of compensated cirrhosis and hepatitis B virus-associated acute-on-chronic liver failure patients enrolled in Study 1, n (%)

    Difference in biomarkers of the gastrointestinal barrier and inflammation

    Compared with the control group, the coccus-bacillus ratio in feces, sIgA in stool, and serum D-lactate were significantly higher in the HBV-ACLF group (Figure 4A-C), which indicated that the intestinal barrier was impaired in HBV-ACLF patients.

    For biomarkers of inflammation, the levels of serum endotoxin, IL-1, IL-10, and TNF-α in the HBV-ACLF group were significantly higher than those of the control group (Figure 4D).

    Nutritional support and prognosis of HBV associated acute-on-chronic liver failure

    According to the survival conditions of the patients at 2 d, the HBV-ACLF patients were divided into a survival group and a death group. The survival group had a lower nutritional risk (SAG scores) (P< 0.001), lower serum D-lactate (P= 0.007), and lower levels of cytokines (P< 0.05) at admission (Table 2). The differences in biomarkers were used to establish an ROC for predicting 28 d mortality. IL-10 had the best result in predicting the death of HBV-ACLF patients (Figure 5A). The cutoff value was 80.5 μg/mL. Other detailed results of ROC are shown in Supplemental Table 1.

    After individualized nutritional support for HBV-ACLF patients, the TSF of survivors did not continue to decrease (P= 0.673). By week 4, the SGA score was significantly improved (P< 0.001). There was no significant change in the coccusbacillus ratio, but the levels of serum D-lactate (P< 0.001) and fecal sIgA (P< 0.001) decreased gradually. Serum endotoxin (P= 0.021), TNF-α (P< 0.001), and IL-1 (P< 0.001) decreased gradually as well, but IL-10 had no significant change (P= 0.402) (Figure 5B).

    In Study 2, the non-nutritional support group had similar age, liver function, renal function, complications, and other clinical characteristics to the nutritional support group (P< 0.05; Table 3). A total of 91 patients (38.9 %) patients died within 28 d in the HBV-ACLF nutritional support group and 102 (49.3%) died in the non-nutritionalsupport group. There was a difference in 28-d survival between the two groups (χ2= 5.812,P= 0.016; Figure 6).

    Table 2 Characteristics of nutritional and gastrointestinal barrier between survival group and death group in hepatitis B virusassociated acute-on-chronic liver failure patients at admission, n (%)

    DISCUSSION

    This study comprehensively assessed the nutritional status, nutritional risk, and gastrointestinal barrier function in patients with HBV-ACLF. We found that improving the nutritional status of HBV-ACLF patients can improve gastrointestinal barrier function and associate with a better prognosis.

    We found that most patients with HBV-ACLF had inadequate nutrient intake and malnutrition at admission or diagnosis. Clinical nutritionists believe that patients with liver cirrhosis should be given nutritional treatment when there is a nutritional risk[20,21]. Thus, the determination of the nutritional status and various nutritional components of the patients at the time of diagnosis or admission is necessary. On this basis, an individualized nutritional support treatment plan has been developed for each patient to meet the needs of the human body and promote the recovery from the disease[7,18].

    We further verified malnutrition in patients with HBV-ACLF by comparing TSF and SGA score. Although anthropometric indexes such as TSF have limitations, they are not affected by ascitic or other factors. Due to their ease of use, anthropometric indexes are used as the evaluation criteria for nutritional status in many studies of malnutrition in liver diseases[22]. However, the time lag is certain regardless of what type of physiologic parameters. In contrast, SGA is a comprehensive index to reflect the nutritional status, which is widely used in the field of liver disease and recommended by the European Association of Parenteral Nutrition for comprehensive nutritional assessment[18]. In addition, Kyleet al[23]screened 995 patients and found that NRS 2002 had higher sensitivity and specificity. NRS 2002 and SGA scores were both used in our study.

    The presence of gastrointestinal barrier impairment in patients with HBV-ACLF is also one of our main findings. Gastrointestinal function and liver function are closely related. Gastrointestinal dysfunction can occur in patients with liver failure in the early stage. At the same time, portal hypertensive gastropathy, portal hypertensive enteropathy, increased abdominal pressure caused by ascites, and intestinal flora disorders, which are the results of liver failure, are also the causes of malnutrition in patients[24]. Finally, a vicious circle is formed, which further affects the function of the gastrointestinal barrier.

    Moreover, this study confirmed that the level of serum D-lactate in patients with chronic liver failure was significantly increased. When the barrier function of thegastrointestinal tract is impaired, intestinal bacteria show excess propagation or intestinal flora translocation occurs, and the production and absorption of endotoxin increase, which further leads to damage to the liver and other organs[25]. Endotoxin has a variety of physiological and pathological effects, such as causing a febrile reaction, activating the complement system, and causing local or systemic Shwartzman reactions and disseminated intravascular coagulation[26]. In addition to the direct effect of endotoxin, the toxic mechanism can also induce the cascade release of cytokines, strongly increase tumor necrosis factor, result in an Th1/Th2 imbalance, and further aggravate the disease and cause death[27]. D-lactate is the product of bacterial metabolism and lysis, which can be produced by a variety of intestinal bacteria[28]. When intestinal permeability increases abnormally, high levels of D-lactate produced by intestinal bacteria enter the circulation through the intestine. The liver cannot metabolize D-lactate, so the level of serum D-lactate can reflect the extent of the impaired gastrointestinal barrier[29].

    Table 3 Baseline characteristics of hepatitis B virus-associated acute-on-chronic liver failure patients enrolled in Study 2, n (%)

    In addition to the intestinal mechanical barrier and biological barrier, there are many plasma cells in the lamina propria of the intestinal mucosa, which mainly secrete sIgA. Intestinal sIgA plays an important role in maintaining intestinal immune surveillance, clearing bacteria, and preventing bacteria from adhering to the mucosa[30]. The detection of intestinal mucosa sIgA content requires intestinal mucosa biopsies for radioimmunity, which is not applicable for patients with HBV-ACLF[31]. Thus, sIgA was measured in the feces. In Study 1, the TSF of the surviving patients did not continue to decrease, indicating that the nutritional status of the patients did not deteriorate further. The further decreases of biomarkers of impaired gastrointestinal function and inflammation in survival were also found after nutritional support. Furthermore, we found that IL-10 is a potential predictor of 28-d death.

    Figure 2 Comparison of nutritional status between the hepatitis B virus-associated acute-on-chronic liver failure group and the control group. A: According to the Nutritional risk screening 2002 assessment, 91.4% of hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) patients and 67.5% of compensated cirrhosis patients had a nutritional risk; B: The energy intake in HBV-ACLF patients was lower than that in compensated cirrhosis patients (P < 0.001); C: The body composition analysis in HBV-ACLF and control group. Significant decreases in skeletal muscle and fat in HBV-ACLF patients were observed; D: The intake of calories, protein, and fat in HBV-ACLF were lower than those in the control group at hospital admission (P < 0.001). HBV-ACLF: Hepatitis B virusassociated acute-on-chronic liver failure.

    In Study 2, a retrospective cohort, we demonstrated that individualized and dynamic nutritional support reduced 28-d mortality. In practice, we found that intravenous infusion of albumin and medium/long-chain fat emulsion can be well tolerated in HBV-ACLF patients. Protein and fat are the dominant source of energy for liver regeneration and hepatocyte turnover. So protein and fat should not be overly restricted in the diet. The administration of parenteral nutrition, including fat emulsion, did not worsen liver function. However, Pierceet al[32]noted that too much fat increases the burden on the liver in mice. This change leads to or aggravates jaundice, increases transaminase and blood glucose, and decreases immune function. Therefore, the supplemental dose of fat should be limited to < 1 g/(kg·d)[33].

    There are some limitations and shortcomings in this study: (1) There are some differences in the definition of acute-on-chronic liver failure among the American Association for the Study of the Liver Diseases, the European Association for the Study of the Liver, and APASL[15]. The subjects were selected according to the consensus recommendations of the APASL; (2) The non-nutritional support group with liver failure was from a retrospective cohort, which may not reflect the situation of all hospitalized patients at the same time; and (3) Some biomarker tests for predicting death in HBV-ACLF patients were based on ELISA, and this result may be affected by the manufacturers of test reagents and measurement errors.

    Figure 3 Difference in triceps skinfold thickness and subjective global assessment score. A: Patients with hepatitis B virus-associated acute-onchronic liver failure (HBV-ACLF) had a higher subjective global assessment score; B: Patients with HBV-ACLF had a lower triceps skinfold thickness. SGA: Subjective global assessment; HBV-ACLF: Hepatitis B virus-associated acute-on-chronic liver failure.

    Figure 4 Comparison of biomarkers of the gastrointestinal barrier and inflammation. A: The coccus-bacillus ratio in feces in the hepatitis B virusassociated acute-on-chronic liver failure (HBV-ACLF) group (1.2 ± 0.2) was higher than that of the control group (1.1 ± 0.3; P < 0.001); B: The level of serum Dlactate in the HBV-ACLF group (358.1 ± 74.6 μg/mL) was higher than that of the control group (8.0 ± 2.1 μg/mL; P < 0.001); C: The level of sIgA in the HBV-ACLF group (358.1 ± 74.6 mg/L) was higher than that of the control group (12.5 ± 4.2) mg/L; P < 0.001); D: The levels of endotoxin, IL-1, IL-10, and TNF-α in HBV-ACLF patients were higher than those in the control group (P < 0.001). HBV-ACLF: Hepatitis B virus-associated acute-on-chronic liver failure; IL-1: Interleukin-1; IL-10: Interleukin-10; TNF-α: Tumor necrosis factor alpha.

    Overall, we performed the nutritional assessment of HBV-ACLF patients for the first time and found that their intestinal peristaltic ability decreased and the intestinal barrier function was damaged. In addition, individualized and dynamic nutritional support was associated with a better prognosis of 28-d mortality in HBV-ACLF patients and can improve the nutritional status of survivors.

    Figure 5 Role of biomarkers in hepatitis B virus-associated acute-on-chronic liver failure patients. A: Value of biomarkers in predicting death in HBV-ACLF patients. The area under the receiver operating characteristic curve of IL-10 was the largest (area under the curve = 0.907, P < 0.001); B: Trends of biomarkers in survivors. HBV-ACLF: Hepatitis B virus-associated acute-on-chronic liver failure; SGA: Subjective global assessment; SIgA: Secretory immunoglobulin A; IL-1: Interleukin-1; IL-10: Interleukin-10; TNF-α: Tumor necrosis factor alpha.

    ARTICLE HIGHLIGHTS

    Research objectives

    To investigate the nutritional risk and nutritional status of HBV-ACLF patients and evaluated the impact of nutritional support on the gastrointestinal barrier and 28-d mortality.

    Research methods

    The nutritional risk screening assessment, baseline characteristics, and biomarkers of the gastrointestinal barrier of patients with HBV-ACLF (n= 234) and patients with compensatory cirrhosis (n= 234) were analyzed. The 28-d survival of the nutritional support group (n= 234) and non-nutritional support group (n= 207) was compared.

    Research results

    The nutritional risk of the HBV-ACLF patients was significantly higher than that of the control group. The coccus-bacillus ratio, secretory immunoglobulin A, and serum Dlactate were significantly increased in HBV-ACLF patients. Interleukin-10 may be a potential predictor of death in HBV-ACLF patients. The 28-d survival of the nutritional support group was better than that of the non-nutritional support group (P= 0.016).

    Research conclusions

    This is the first study to investigate the nutritional risk and status of HBV-ACLF patients and evaluated the impact of nutritional support. We found that nutritional support initiated promptly for malnourished HBV-ACLF patients was associated with a better prognosis of 28-d mortality and improved the status of the gastrointestinal barrier.

    Research perspectives

    More attention should be paid to nutritional risk screening and corresponding nutritional support for HBV-ACLF patients. Nutritional support initiated promptly for malnourished HBV-ACLF patients is associated with a better prognosis.

    ACKNOWLEDGEMENTS

    We kindly thank all of the participants in this study.

    色播在线永久视频| АⅤ资源中文在线天堂| www.www免费av| 人人妻人人澡人人看| 精品久久久久久久久久久久久 | avwww免费| 波多野结衣高清作品| 亚洲精华国产精华精| 国产v大片淫在线免费观看| 久久精品国产综合久久久| 亚洲成人久久性| 免费在线观看完整版高清| 99久久无色码亚洲精品果冻| 久久草成人影院| 国产熟女xx| 91字幕亚洲| АⅤ资源中文在线天堂| 黄色片一级片一级黄色片| 欧美一级a爱片免费观看看 | 国产午夜精品久久久久久| 午夜福利在线观看吧| 特大巨黑吊av在线直播 | 18禁美女被吸乳视频| 女警被强在线播放| 亚洲国产欧美网| 国产爱豆传媒在线观看 | 亚洲一卡2卡3卡4卡5卡精品中文| 日日摸夜夜添夜夜添小说| 999精品在线视频| 天天一区二区日本电影三级| 99国产精品99久久久久| 国产精品乱码一区二三区的特点| 久久久久国产精品人妻aⅴ院| 日韩免费av在线播放| 国产一区在线观看成人免费| 18禁国产床啪视频网站| 欧美日韩中文字幕国产精品一区二区三区| 亚洲国产精品成人综合色| 高清毛片免费观看视频网站| 久久久精品国产亚洲av高清涩受| 国产久久久一区二区三区| 黑人操中国人逼视频| 悠悠久久av| 999久久久精品免费观看国产| 天天躁夜夜躁狠狠躁躁| 久久婷婷人人爽人人干人人爱| 俄罗斯特黄特色一大片| 桃红色精品国产亚洲av| tocl精华| 欧美日韩一级在线毛片| www国产在线视频色| 亚洲avbb在线观看| xxx96com| 看黄色毛片网站| 777久久人妻少妇嫩草av网站| 成人特级黄色片久久久久久久| 18禁观看日本| 美女午夜性视频免费| 午夜免费观看网址| 久久久国产精品麻豆| 中亚洲国语对白在线视频| 国内精品久久久久久久电影| 国内精品久久久久久久电影| 黑人操中国人逼视频| 人人妻人人澡欧美一区二区| 欧美zozozo另类| 午夜福利成人在线免费观看| 亚洲人成网站在线播放欧美日韩| 国产精品二区激情视频| 久久久精品国产亚洲av高清涩受| 色播在线永久视频| 国产野战对白在线观看| 男女视频在线观看网站免费 | 成人欧美大片| 亚洲自拍偷在线| 制服丝袜大香蕉在线| 国产区一区二久久| 岛国在线观看网站| 亚洲,欧美精品.| 91国产中文字幕| 国产成人av激情在线播放| 国产一级毛片七仙女欲春2 | 欧美精品亚洲一区二区| 国产精品久久久久久精品电影 | 神马国产精品三级电影在线观看 | 久久久久久亚洲精品国产蜜桃av| 欧美日韩精品网址| 亚洲成av片中文字幕在线观看| 久久久国产成人免费| 久久国产亚洲av麻豆专区| 午夜福利在线在线| 少妇裸体淫交视频免费看高清 | 最近最新中文字幕大全电影3 | 久久精品91无色码中文字幕| 高潮久久久久久久久久久不卡| 国产高清视频在线播放一区| 黄色视频,在线免费观看| 女人被狂操c到高潮| 欧美激情久久久久久爽电影| 婷婷六月久久综合丁香| 精品欧美国产一区二区三| 中文字幕av电影在线播放| 亚洲精品在线观看二区| 免费搜索国产男女视频| 国内精品久久久久精免费| 悠悠久久av| 亚洲av电影在线进入| 十分钟在线观看高清视频www| 日本熟妇午夜| 天堂动漫精品| 首页视频小说图片口味搜索| 日本成人三级电影网站| 亚洲av日韩精品久久久久久密| 成人国产一区最新在线观看| 亚洲性夜色夜夜综合| 桃色一区二区三区在线观看| 日本熟妇午夜| 精品乱码久久久久久99久播| 夜夜夜夜夜久久久久| 两性午夜刺激爽爽歪歪视频在线观看 | 麻豆久久精品国产亚洲av| 亚洲精品粉嫩美女一区| 精品日产1卡2卡| 麻豆成人av在线观看| 亚洲久久久国产精品| 黄色片一级片一级黄色片| 中文字幕精品免费在线观看视频| 精华霜和精华液先用哪个| 男女视频在线观看网站免费 | 国产成人欧美| 日本免费a在线| 国产精品久久电影中文字幕| 亚洲中文字幕一区二区三区有码在线看 | 亚洲中文字幕日韩| av在线天堂中文字幕| av片东京热男人的天堂| 国内精品久久久久精免费| 不卡av一区二区三区| 午夜久久久在线观看| 曰老女人黄片| 久久婷婷人人爽人人干人人爱| av视频在线观看入口| 免费看日本二区| 成人永久免费在线观看视频| 精品人妻1区二区| 久久久水蜜桃国产精品网| 国产av又大| 黑人欧美特级aaaaaa片| 又黄又爽又免费观看的视频| 国内揄拍国产精品人妻在线 | 亚洲免费av在线视频| 亚洲中文日韩欧美视频| 日韩欧美 国产精品| 美女高潮到喷水免费观看| 无人区码免费观看不卡| 久久 成人 亚洲| 伊人久久大香线蕉亚洲五| 国产欧美日韩精品亚洲av| 久久久久国内视频| 国产亚洲欧美精品永久| 一级毛片高清免费大全| 欧美日韩黄片免| 丰满的人妻完整版| 久久久久久久精品吃奶| 亚洲avbb在线观看| 亚洲一区中文字幕在线| 日韩欧美 国产精品| av欧美777| 亚洲国产欧洲综合997久久, | 老司机在亚洲福利影院| 波多野结衣av一区二区av| 十八禁网站免费在线| 色精品久久人妻99蜜桃| 成人三级做爰电影| 久久久久免费精品人妻一区二区 | 亚洲无线在线观看| 操出白浆在线播放| 精品国产乱子伦一区二区三区| 不卡一级毛片| 国产精品久久久久久精品电影 | 亚洲精品在线观看二区| 亚洲狠狠婷婷综合久久图片| 别揉我奶头~嗯~啊~动态视频| 国产精品电影一区二区三区| 国产成人欧美| 亚洲无线在线观看| 国产欧美日韩一区二区精品| 日本在线视频免费播放| 欧美乱码精品一区二区三区| 午夜视频精品福利| 亚洲,欧美精品.| 嫁个100分男人电影在线观看| 欧美中文综合在线视频| 一本大道久久a久久精品| 波多野结衣高清无吗| 88av欧美| 在线观看午夜福利视频| 午夜久久久在线观看| 欧美日韩精品网址| 日韩欧美一区二区三区在线观看| 亚洲七黄色美女视频| 成熟少妇高潮喷水视频| 欧美+亚洲+日韩+国产| 啪啪无遮挡十八禁网站| 9191精品国产免费久久| 亚洲精品美女久久久久99蜜臀| 在线av久久热| 日韩中文字幕欧美一区二区| 国产成人精品久久二区二区91| 50天的宝宝边吃奶边哭怎么回事| 男女下面进入的视频免费午夜 | 又紧又爽又黄一区二区| 国产伦人伦偷精品视频| 黄片播放在线免费| 久久亚洲精品不卡| 两人在一起打扑克的视频| 欧美成人午夜精品| 亚洲七黄色美女视频| 看免费av毛片| 他把我摸到了高潮在线观看| www国产在线视频色| 国产一区二区三区视频了| 亚洲av第一区精品v没综合| 日韩大尺度精品在线看网址| 日本 av在线| 久99久视频精品免费| www日本在线高清视频| 一二三四社区在线视频社区8| 亚洲一区高清亚洲精品| 欧美一区二区精品小视频在线| 啪啪无遮挡十八禁网站| 欧美乱码精品一区二区三区| 国产三级黄色录像| xxx96com| 国产av一区二区精品久久| 无人区码免费观看不卡| 丝袜在线中文字幕| 在线观看午夜福利视频| 亚洲一区中文字幕在线| 欧美日韩亚洲综合一区二区三区_| 日本一本二区三区精品| 日韩欧美一区视频在线观看| 成年女人毛片免费观看观看9| 黄色 视频免费看| 亚洲av熟女| 国产一区二区激情短视频| 少妇的丰满在线观看| 亚洲中文字幕一区二区三区有码在线看 | 自线自在国产av| 欧美黑人巨大hd| 91九色精品人成在线观看| 亚洲精品色激情综合| 成年女人毛片免费观看观看9| 99久久久亚洲精品蜜臀av| 夜夜爽天天搞| 女性被躁到高潮视频| 男女床上黄色一级片免费看| 国产成人啪精品午夜网站| 午夜免费成人在线视频| 国产真实乱freesex| 欧美精品亚洲一区二区| 国产黄色小视频在线观看| 国产精品电影一区二区三区| 欧美黑人欧美精品刺激| 91大片在线观看| 成人三级黄色视频| 日本撒尿小便嘘嘘汇集6| 精品国产超薄肉色丝袜足j| 亚洲一码二码三码区别大吗| 又黄又粗又硬又大视频| 亚洲精品国产精品久久久不卡| 级片在线观看| 国产高清激情床上av| 日本撒尿小便嘘嘘汇集6| 国产一区二区三区视频了| 一级片免费观看大全| 香蕉久久夜色| 91成年电影在线观看| 国产片内射在线| 色在线成人网| 女警被强在线播放| 老汉色∧v一级毛片| 一个人观看的视频www高清免费观看 | 欧美日韩乱码在线| 9191精品国产免费久久| 久久久久久大精品| 一级毛片高清免费大全| 国产精品九九99| 亚洲欧洲精品一区二区精品久久久| 亚洲成人精品中文字幕电影| 在线看三级毛片| 日韩欧美 国产精品| 日韩高清综合在线| 精品不卡国产一区二区三区| 少妇裸体淫交视频免费看高清 | 中文在线观看免费www的网站 | 国内揄拍国产精品人妻在线 | 好男人电影高清在线观看| 俺也久久电影网| 免费无遮挡裸体视频| 欧美日韩亚洲综合一区二区三区_| 亚洲精品av麻豆狂野| 亚洲av美国av| 午夜福利成人在线免费观看| 国产又色又爽无遮挡免费看| 精品欧美一区二区三区在线| 亚洲中文字幕一区二区三区有码在线看 | 亚洲美女黄片视频| 桃色一区二区三区在线观看| 国产男靠女视频免费网站| 亚洲成人久久爱视频| 国产99白浆流出| 日韩高清综合在线| 老司机深夜福利视频在线观看| 亚洲av电影在线进入| 脱女人内裤的视频| 午夜免费观看网址| 国产精品永久免费网站| 国产主播在线观看一区二区| xxxwww97欧美| 精品人妻1区二区| 18禁黄网站禁片午夜丰满| 身体一侧抽搐| 国产成人影院久久av| 美女国产高潮福利片在线看| 欧美在线一区亚洲| 曰老女人黄片| av超薄肉色丝袜交足视频| 亚洲午夜理论影院| 黑丝袜美女国产一区| 久久 成人 亚洲| 国产av不卡久久| 精品一区二区三区av网在线观看| 久久久久久久久久黄片| 久久热在线av| www.999成人在线观看| 中文字幕最新亚洲高清| 国产91精品成人一区二区三区| 国产久久久一区二区三区| 男人舔女人下体高潮全视频| 亚洲成人久久爱视频| 成人av一区二区三区在线看| 亚洲成人久久爱视频| 一区二区三区高清视频在线| 国产极品粉嫩免费观看在线| 91字幕亚洲| 免费在线观看黄色视频的| 99久久久亚洲精品蜜臀av| 国产av又大| 侵犯人妻中文字幕一二三四区| 国产伦人伦偷精品视频| 日韩欧美国产在线观看| 91麻豆精品激情在线观看国产| www.熟女人妻精品国产| 欧美午夜高清在线| 国产在线精品亚洲第一网站| АⅤ资源中文在线天堂| 精品久久久久久久人妻蜜臀av| 国产三级黄色录像| 精品卡一卡二卡四卡免费| 久久久国产精品麻豆| 麻豆一二三区av精品| 琪琪午夜伦伦电影理论片6080| 免费一级毛片在线播放高清视频| 一个人免费在线观看的高清视频| 美国免费a级毛片| 免费看美女性在线毛片视频| 日韩国内少妇激情av| 免费女性裸体啪啪无遮挡网站| 一本综合久久免费| av视频在线观看入口| 日韩精品中文字幕看吧| 母亲3免费完整高清在线观看| 成人国产综合亚洲| 母亲3免费完整高清在线观看| 精品福利观看| 嫁个100分男人电影在线观看| 日韩中文字幕欧美一区二区| 欧美人与性动交α欧美精品济南到| 亚洲成人久久性| 在线观看日韩欧美| 欧美+亚洲+日韩+国产| 99热6这里只有精品| 动漫黄色视频在线观看| 成人午夜高清在线视频 | 日韩欧美在线二视频| 精品一区二区三区视频在线观看免费| a级毛片在线看网站| 一本综合久久免费| 亚洲久久久国产精品| 亚洲男人的天堂狠狠| 日本免费一区二区三区高清不卡| 久久精品成人免费网站| 日本熟妇午夜| 淫秽高清视频在线观看| 91老司机精品| 国产私拍福利视频在线观看| 国产成人av教育| 亚洲成人免费电影在线观看| 夜夜爽天天搞| 日韩国内少妇激情av| 国产精品自产拍在线观看55亚洲| 日日夜夜操网爽| 国产精品久久久久久精品电影 | 午夜福利欧美成人| 很黄的视频免费| 日本黄色视频三级网站网址| 18美女黄网站色大片免费观看| 欧美绝顶高潮抽搐喷水| a级毛片a级免费在线| 久久国产精品人妻蜜桃| 久久婷婷人人爽人人干人人爱| 亚洲avbb在线观看| 亚洲美女黄片视频| tocl精华| 亚洲中文字幕日韩| 精华霜和精华液先用哪个| 亚洲人成电影免费在线| 国产视频一区二区在线看| 国产高清有码在线观看视频 | 国内久久婷婷六月综合欲色啪| 国产在线观看jvid| 美女 人体艺术 gogo| 亚洲成人久久性| 国产色视频综合| 国产乱人伦免费视频| 午夜亚洲福利在线播放| 国产在线精品亚洲第一网站| 精品国产一区二区三区四区第35| 热99re8久久精品国产| 欧美三级亚洲精品| 日日干狠狠操夜夜爽| 国产1区2区3区精品| 亚洲av美国av| 久久伊人香网站| 巨乳人妻的诱惑在线观看| 在线看三级毛片| ponron亚洲| 久久九九热精品免费| 国产精品98久久久久久宅男小说| 午夜亚洲福利在线播放| 热re99久久国产66热| 亚洲精品美女久久av网站| 高清在线国产一区| 国产一卡二卡三卡精品| 久久国产亚洲av麻豆专区| 欧美激情高清一区二区三区| 久热爱精品视频在线9| 两性夫妻黄色片| 伊人久久大香线蕉亚洲五| 女人被狂操c到高潮| 草草在线视频免费看| 亚洲在线自拍视频| 国产亚洲欧美在线一区二区| 天天一区二区日本电影三级| 黄片大片在线免费观看| 大型黄色视频在线免费观看| 特大巨黑吊av在线直播 | 日本一本二区三区精品| 91成年电影在线观看| 亚洲国产精品sss在线观看| 特大巨黑吊av在线直播 | 亚洲av片天天在线观看| 欧美在线一区亚洲| 999精品在线视频| 国产日本99.免费观看| 国产不卡一卡二| 色尼玛亚洲综合影院| 欧美黄色片欧美黄色片| 99久久99久久久精品蜜桃| 国产成人精品久久二区二区91| 亚洲三区欧美一区| 三级毛片av免费| 精华霜和精华液先用哪个| 欧美大码av| 视频区欧美日本亚洲| 国产亚洲精品综合一区在线观看 | 欧美日韩一级在线毛片| 美女免费视频网站| 久久久久久久久免费视频了| 久久久精品欧美日韩精品| 婷婷亚洲欧美| 亚洲成av人片免费观看| 欧美亚洲日本最大视频资源| xxxwww97欧美| 免费av毛片视频| 中文字幕av电影在线播放| 精品免费久久久久久久清纯| 熟女电影av网| 97超级碰碰碰精品色视频在线观看| 日本 av在线| 啦啦啦韩国在线观看视频| 极品教师在线免费播放| 婷婷精品国产亚洲av| 国产精品 国内视频| 午夜视频精品福利| 少妇的丰满在线观看| 宅男免费午夜| 色综合婷婷激情| 久久亚洲真实| 亚洲全国av大片| 精品午夜福利视频在线观看一区| 美女高潮喷水抽搐中文字幕| 91在线观看av| 日韩大码丰满熟妇| 国产精品久久久久久亚洲av鲁大| 日本在线视频免费播放| 久久久国产精品麻豆| 免费无遮挡裸体视频| 一级作爱视频免费观看| 亚洲国产看品久久| 成人欧美大片| 啪啪无遮挡十八禁网站| 国产爱豆传媒在线观看 | 777久久人妻少妇嫩草av网站| 亚洲一卡2卡3卡4卡5卡精品中文| www日本黄色视频网| 怎么达到女性高潮| 久久精品国产亚洲av高清一级| 久久久久久免费高清国产稀缺| 最新在线观看一区二区三区| 在线免费观看的www视频| 欧美乱码精品一区二区三区| 嫁个100分男人电影在线观看| 精品人妻1区二区| 亚洲欧洲精品一区二区精品久久久| 淫秽高清视频在线观看| 久久国产精品影院| 久久这里只有精品19| 一区二区日韩欧美中文字幕| 精品高清国产在线一区| 精品久久久久久久末码| 波多野结衣高清无吗| 国产av一区在线观看免费| a级毛片a级免费在线| 久久国产精品影院| 在线看三级毛片| 国产一卡二卡三卡精品| 国产亚洲精品一区二区www| 桃红色精品国产亚洲av| 日韩成人在线观看一区二区三区| 我的亚洲天堂| 满18在线观看网站| 999久久久国产精品视频| 国产激情久久老熟女| 女性生殖器流出的白浆| 777久久人妻少妇嫩草av网站| 无人区码免费观看不卡| 他把我摸到了高潮在线观看| 搡老熟女国产l中国老女人| 男人的好看免费观看在线视频 | 99国产综合亚洲精品| 成人特级黄色片久久久久久久| 成人国语在线视频| 一二三四社区在线视频社区8| 色婷婷久久久亚洲欧美| 国产精品美女特级片免费视频播放器 | 好看av亚洲va欧美ⅴa在| 这个男人来自地球电影免费观看| 国产野战对白在线观看| 夜夜躁狠狠躁天天躁| 国产高清有码在线观看视频 | 一a级毛片在线观看| 国产激情欧美一区二区| 中亚洲国语对白在线视频| 午夜免费成人在线视频| 中文在线观看免费www的网站 | 精品午夜福利视频在线观看一区| 国产一区二区在线av高清观看| 老司机在亚洲福利影院| 亚洲人成伊人成综合网2020| 精品乱码久久久久久99久播| 欧美国产精品va在线观看不卡| 在线观看免费午夜福利视频| 在线永久观看黄色视频| 国产亚洲精品一区二区www| 成年人黄色毛片网站| 亚洲第一av免费看| 黄色毛片三级朝国网站| 麻豆av在线久日| 村上凉子中文字幕在线| 欧美一级a爱片免费观看看 | 精品久久久久久久久久久久久 | 亚洲中文日韩欧美视频| 久久久久九九精品影院| 亚洲自拍偷在线| 国产精品电影一区二区三区| 久久天躁狠狠躁夜夜2o2o| 亚洲自拍偷在线| 国产激情欧美一区二区| 免费看十八禁软件| 无遮挡黄片免费观看| 日日夜夜操网爽| 在线观看午夜福利视频| 国产精品久久久av美女十八| 亚洲精品av麻豆狂野| 日韩大码丰满熟妇| 国产又爽黄色视频| 国产成人精品久久二区二区免费| 在线观看免费日韩欧美大片| 午夜福利欧美成人| netflix在线观看网站| 制服诱惑二区| 国产高清激情床上av| 亚洲一区二区三区不卡视频| 久久午夜亚洲精品久久| 一区二区日韩欧美中文字幕| av电影中文网址| 亚洲人成电影免费在线| 国产一卡二卡三卡精品| 欧美日韩瑟瑟在线播放| 午夜老司机福利片| 免费在线观看完整版高清| 欧美不卡视频在线免费观看 | 亚洲自偷自拍图片 自拍|